Pulse dose corticosteroid therapy regimens, both in the form of oral and intravenous administration, are therapeutically beneficial and have a good safety profile in the improvement of AA in the pediatric population. Studies report the…
MDNewsline DailyDecember 23, 2022
Despite the increased incidence of common and viral infections in individuals with AA, this study found no clinically significant association between AA and increased risk for infections. Alopecia areata (AA) is a prevalent autoimmune disorder…
MDNewsline DailyDecember 23, 2022
Baricitinib is safe and effective for the treatment of severe alopecia areata as compared to placebo in two phase 3 randomized controlled trials. Alopecia areata (AA) is an autoimmune condition that causes hair loss in…
MDNewsline DailyDecember 21, 2022
The therapeutic efficacy of Jessner solution is comparable to an injectable intralesional steroid for improving multifocal patchy alopecia areata. Alopecia areata (AA) is referred to as an autoimmune disorder characterized by non-scarring loss of hair.…
MDNewsline DailyDecember 21, 2022
Dermatologist Dr. Edidiong Kaminska, MD, has been in medicine for more than 13 years and practices in Chicago, Illinois. Dr. Kaminska has a wealth of knowledge on skin conditions. We discuss the topic of racial…
Daysha RobinsonNovember 2, 2022
In this interview, we speak with Dr. Kaminska about Olumiant about a novel treatment for alopecia. In addition to explaining what it is and why it can be a good option for certain patients, Dr.…
Daysha RobinsonOctober 25, 2022
There is an association between the development/exacerbation of AA and SARS-CoV-2 infection. However, more studies are required to evaluate this association and contribute to improvement in the dermatological and psychological outcomes in patients with COVID-19.…
Daysha RobinsonOctober 12, 2022
A recent systematic review assessed different treatment modalities for pediatric Alopecia areata (AA). Topical corticosteroids are the first-line treatment of AA in children. Alopecia areata (AA) is an auto-immune disorder that involves non-scarring hair loss.…
Daysha RobinsonOctober 12, 2022
The treatment of AA with brepocitinib and ritlecitinib is associated with a reduction in the SALT scores. This is also related to the downregulation of TH1 cells and the upregulation of hair keratins. Future clinical…
Daysha RobinsonOctober 6, 2022
A group of 22 US board-certified dermatologists have endorsed the alopecia areata (AA) disease severity scale. The scale assesses the extent of hair loss on the scalp, hair loss in the special hair-bearing sites, previous…
Daysha RobinsonOctober 6, 2022